In the 2019 clinical diagnostic criteria for CP [3, 4], mutations in established pancreatitis-associated genes, such as PRSS1 and SPINK1, are included in the diagnostic items for early stage CP, and the role of genetic testing in daily clinical practice is increasing. This evidence concerns the gene SPINK1 and pancreatitis.